Dow Up 0.51% Nasdaq Up 0.24%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
6.50 Down 0.12(1.81%) Nov 21, 4:00PM EST
Prev Close:6.62
Open:6.75
Bid:5.23 x 400
Ask:8.28 x 1000
1y Target Est:10.33
Beta:3.45
Next Earnings Date:N/A
Day's Range:6.37 - 6.75
52wk Range:5.22 - 13.64
Volume:338,114
Avg Vol (3m):660,878
Market Cap:284.10M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACRX

Comparison

Symbol% ChgMkt Cap
ACRXDown 1.81%284.10M
BAXUp 0.63%39.26B
CFNDown 0.03%11.88B
HSPUp 0.50%9.95B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.88
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.95
Quarterly EPS Est (Dec-14) :-0.30
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback